Immunocore Holdings PLC (IMCR)

Currency in USD
31.32
-1.18(-3.63%)
Real-time Data·

IMCR Financial Summary

Key Ratios

P/E Ratio-76.4
Price/Book4.38
Debt / Equity114.67%
Return on Equity-5.86%
Dividend Yield0.00%
EBITDA-48.21M
Fair ValueUnlock
Fair Value UpsideUnlock

Statements Highlights

Period Ending:
2015
31/12
2016
31/12
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
2024
31/12
* In Millions of GBP (except for per share items)

Analyst Ratings

13 Buy
3 Hold
1 Sell
Ratings:
17 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 62.45
(+99.38% Upside)

Earnings

Latest Release
May 07, 2025
EPS / Forecast
0.10 / -0.39
Revenue / Forecast
93.88M / 86.10M
EPS Revisions
Last 90 days

FAQ

What were Immunocore Holdings's earnings for the latest quarter?

The Immunocore Holdings EPS (TTM) is -0.43. Immunocore Holdings reported sales of 93.88, net income of 5.02, and EPS of 0.10 for the latest quarter.

What was Immunocore Holdings's net income for the latest quarter?

Immunocore Holdings's net income for the latest quarter was 5.02.

How did Immunocore Holdings's performance compare year-over-year in the latest quarter?

The company's revenue moved from 84.05 in the previous quarter to 93.88 in the latest quarter, and net income moved from -23.77 to 5.02 compared to the previous quarter.

What is Immunocore Holdings's net profit margin on a TTM basis?

Immunocore Holdings's trailing twelve months (TTM) net profit margin is -16.47%.

How does Immunocore Holdings's debt to equity ratio compare to industry standards?

Immunocore Holdings's total debt-to-equity ratio is 114.67%.

What is Immunocore Holdings's return on investment on a TTM basis?

Immunocore Holdings's trailing twelve months (TTM) return on investment (ROI) is -5.86%.

Did Immunocore Holdings gain or lose cash last quarter?

In the latest quarter, Immunocore Holdings's net change in cash was 16.34 million.

What were Immunocore Holdings's total assets and liabilities in the latest quarter?

As of the latest quarter, Immunocore Holdings reported total assets of 1,028.01 million and total liabilities of 149.16 million.

How has Immunocore Holdings's total revenue grown this year?

Immunocore Holdings's total revenue was 84.05 in the previous quarter and 93.88 in the latest quarter.

What is Immunocore Holdings's gross margin on a TTM basis?

Immunocore Holdings's trailing twelve months (TTM) gross margin is 96.68%.

What was Immunocore Holdings's revenue per share for the latest quarter?

Immunocore Holdings's revenue per share for the latest quarter was 43.83.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.